This activity has been designed to meet the educational needs of nurse practitioners.
At the conclusion of this activity, the learner will be better able to:
- Identify the appropriate indications for insulin aspart.
- Summarize the appropriate dosing of insulin aspart as part of a glycemic control regimen.
- Describe the potential adverse event profile and contraindications of insulin aspart.
- Outline interprofessional team strategies for improving care coordination and communication to advance appropriate clinical outcomes with insulin aspart therapy as part of a diabetes mellitus glycemic control treatment plan leading to optimal patient outcomes.
- Outline the indications of Aspart Insulin
Author(s) / Contributors Disclosure of Conflicts of Interest
Hover over the contributor names to see details and disclosures of any financial relationships they have with commercial interests related to the content of this continuing education activity. All of the relevant financial relationships listed for these individuals have been mitigated.
COMMERCIAL SUPPORT: This activity has received NO commercial support.
- Authors: Rochelle Rubin, Niloufar Khanna
- Editors: Lindsey McIver
- Editors-In-Chief: George GriffingSusan Berg
Chief Medical Reviewer: Mark Pellegrini
- Nurse Planner/Reviewer/Editor:Lisa Haddad
- Nurse Planner/Reviewer/Editor:Bernadette Makar
- Nurse Planner/Reviewer/Editor:Dorothy Caputo
- Pharmacy Planner/Reviewer/Editor:Mark Pellegrini
- Physician Planner/Reviewer/Editor:Scott Dulebohn
Continuing Education Accreditation Information
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and StatPearls Publishing, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 1.00 hour(s) of pharmacology).
Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.
- StatPearls and AKH reserve the right to cancel any course due to unforeseen circumstances. StatPearls and AKH will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.
- StatPearls and AKH are Equal Opportunity / Affirmative Action / Equal Access Institutions.
Medium or Media Used:
- Computer Requirements: Internet Access
- E-mail Address
Instructions for Credit
- Register for the activity and create a StatPearls login.
- Review the required accreditation information: Target audience, learning objectives, and disclosure information.
- Complete the entire self-study activity.
- Complete the post-test assessments.
- Successfully pass the post-test with a minimum score of 100%.
- Complete the evaluation form.
- Obtain a certificate.
StatPearls and AKH adhere to provider standards regarding commercial support of continuing education. It is the policy of StatPearls and AKH that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
- If you have concerns regarding the CE system, please contact email@example.com, or call 727-289-9796.
- If you have concerns regarding CE, please contact firstname.lastname@example.org or call AKH 877-AKH-CME4.
Conflict of Interest Disclosure Policy:
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use:
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Media Usage Rights
The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity. All copyrights are reserved.